The derepression of enzymes of de novo pyrimidine biosynthesis pathway in Brevibacterium ammoniagenes producing uridine-5-monophosphate and uracil.
A mutant of Brevibacterium ammoniagenes producing large quantities of UMP and uracil is described. The mutations render bacteria braditrophic for arginine, sensitive to adenine, resistant to rifampicin and pyrimidine analogues 5-fluorouracil, 5-fluorouridine, azauracil and thiouracil. The activities of enzymes involved in the UMP biosynthesis, i.e. orotate phosphoribosyltransferase, orotate-5-monophosphate decarboxylase, dihydroorotate oxidase, are 4-, 3.5- and 4.5-fold higher in the mutant than in the parent strain when grown in minimal medium. The synthesis of these enzymes in mutant cells is not repressed in the presence of exogenous Ura. True revertants, which completely restore the wild-type phenotype, occur among the Arg+ clones. The nature of the mutation is discussed.
Nudler
A A
AA
Institute of Genetics and Selection of Industrial Microorganisms, Moscow, U.S.S.R.
Garibyan
A G
AG
Bourd
G I
GI
D001951:Brevibacterium / Q000235:genetics / Q000378:metabolism*; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D015964:Gene Expression Regulation, Bacterial; D009154:Mutation; D011743:Pyrimidines / Q000096:biosynthesis*; D014498:Uracil / Q000096:biosynthesis; D014542:Uridine Monophosphate / Q000096:biosynthesis
D011743:Pyrimidines; D014498:Uracil; D014542:Uridine Monophosphate; D012321:DNA-Directed RNA Polymerases